Abstract
This article presents a series of multidisciplinary case studies on neuro-oncology disorders, encompassing aspects such as administration, clinical and pharmacological approaches, organizational and legal frameworks, and pharmaceutical management. A comprehensive plan has been developed for studying neuro-oncology disorders amid comorbid conditions in the context of military conflicts. The research outlines key directions, including the scientific hypothesis, objectives, anticipated innovations, research design, study subjects, methodologies, endpoints, evidence levels, and descriptions of scientific and technical products. Various facets of project effectiveness are detailed, emphasizing the discovery of new correlations between neuro-oncology disorders and comorbid conditions, paving the way for innovative therapeutic methods. The research design includes specific indicators of treatment effectiveness, covering assessment, diagnosis, pharmacotherapy, psychosocial support, psychocorrection, and strategies for professional reintegration. The degree of evidence and effectiveness is thoroughly evaluated. The study is expected to yield highly credible results that will enhance the optimization of neuro-oncology disorder treatments, improving medical, pharmaceutical, social, and economic outcomes. By integrating these multidisciplinary approaches, the research aims to significantly advance the understanding and management of neuro-oncology disorders, particularly in challenging environments such as military conflict zones.
Publisher
Shapovalov Scientific Publishing OU (Publications)
Reference28 articles.
1. Afonso M., Brito M.A. Therapeutic options in Neuro-Oncology. Int J. Mol. Sci. 2022. Vol.23. No.10. P.e5351. DOI: https://doi.org/10.3390/ijms23105351
2. Shapovalov (Jr.) V., Shapovalova V., Gudzenko A. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol.51. Nо.1. P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf
3. Shapovalova V. The ICD-11 for the twenty-first century: the first view from the organizational, legal, clinical and pharmacological aspects. SSP Modern Pharmacy and Medicine. 2022. Vol.2. Nо.1. Р.1–13. URL: https://doi.org/10.53933/sspmpm.v2i1.37
4. Shapovalov V. Multidisciplinary study of the level of availability of medicines for cancer patients based on the principles of pharmaceutical law, evidence-based pharmacy, clinical pharmacy, forensic pharmacy, and the organization of a pharmaceutical case. Actual Problems of Medicine and Pharmacy. 2023. Vol.4. No.1. P.1–20. URL: https://doi.org/10.52914/apmp.v4i1.52
5. Shapovalov V.V. (Jr.), Zbrozhek S.I., Shapovalova V.O. et al. Organizational and legal evaluation of availability of medicines’ circulation for cancer patients Pharmacia. 2018. Vol.65. Nо.2. P.17-22. URL: http://bsphs.org/?magasine=organizational-and-legal-evaluation-of-availability-of-medicines-circulation-for-cancer-patients.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献